Abstractive Health vs Pieces
The two records in this category that have both been tested on accuracy, in opposite ways. Abstractive tested itself, publishing an evaluation in a peer reviewed journal that reported its summaries as marginally inferior to physicians, with every sentence traceable to its source note and a complete compliance stack behind it. Pieces was tested by a state attorney general, whose September 2024 settlement over accuracy claims remains the only case in this index of an outside authority examining what a healthcare AI company says about its own performance. One volunteered scrutiny and one received it, and both now publish more than competitors who have had neither. Pieces also reaches case management and utilisation review, which nothing else here addresses.
- It published its own evaluation in a peer reviewed journal with a result unfavourable to the product, and links every sentence of a summary to its source note.
- The compliance position is complete and inspectable: a typed attestation, a public trust centre, a published business associate agreement and a published price ladder.
- It is a direct implementer on the national exchange framework rather than a consumer of someone else's connection.
- It is the only product in this category that explicitly addresses case management and utilisation review rather than only the clinician.
- Its oversight architecture was developed under external scrutiny rather than in the abstract, which is worth weighing alongside the enforcement history.
- It now sits inside a group publishing a genuine trust centre with named compliance items.
Side by Side
| Axis | A Abstractive Health |
P Pieces |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
In September 2024 the Texas Attorney General settled with Pieces over its accuracy claims, the first enforcement action of its kind against a healthcare AI vendor, which is both a real governance failure and the only instance here of an outside authority examining a clinical AI company's self reported performance; read the settlement terms rather than the headline. Abstractive has named itself into a regulatory category it has not addressed, with no clearance, authorisation or exemption analysis located. Neither publishes an omission rate.